Cholecalciferol, also known as vitamin D3, is a fat-soluble secosteroid crucial for calcium homeostasis and bone metabolism. It plays a vital role in maintaining skeletal integrity and is essential for proper functioning of the musculoskeletal, immune, and endocrine systems. Produced endogenously when the skin is exposed to ultraviolet B (UVB) rays from sunlight, cholecalciferol is also available as a dietary supplement and is widely used in clinical settings to treat and prevent vitamin D deficiency and associated disorders.
Chemical Structure
Cholecalciferol belongs to the class of secosteroids, which are steroids with a “broken” ring. It has the molecular formula C27H44O and a molecular weight of approximately 384.64 g/mol. Structurally, cholecalciferol is derived from 7-dehydrocholesterol, a cholesterol precursor in the skin. Upon UVB radiation, a photochemical reaction transforms 7-dehydrocholesterol into pre-vitamin D3, which is then thermally isomerized into cholecalciferol.
Its structure consists of three intact six-membered rings and a broken fourth ring, typical of secosteroids, and includes a hydroxyl group at the 3-beta position, which is critical for further hydroxylation and activation in the liver and kidneys.
Cholecalciferol-Based Medicines List
- Calcitriol (Rocaltrol) – A potent vitamin D analog, typically used in renal osteodystrophy.
- Drisdol – A common oral formulation of vitamin D2 but closely related to D3 therapy contexts.
- Cholecalciferol (D3-Vita) – A direct supplement for vitamin D3 replenishment.
- Vitron-C with D3 – Combination of iron, vitamin C, and D3 for anemia and deficiency management.
- Dialyvite with D3 – Used in dialysis patients requiring vitamin D repletion.
- Caltrate D3 – A calcium and vitamin D3 supplement for osteoporosis.
- Maxi-D3 5000 IU – A high-dose vitamin D3 softgel used for rapid correction of deficiency.
- One-A-Day with Vitamin D3 – A multivitamin that includes D3 to support bone and immune health.
Mechanism of Action
Cholecalciferol is biologically inactive until it undergoes two hydroxylation steps. The first occurs in the liver, converting cholecalciferol into 25-hydroxyvitamin D3 (calcidiol). The second occurs in the kidneys, where it is converted into the active form, 1,25-dihydroxyvitamin D3 (calcitriol).
Calcitriol acts as a hormone by binding to vitamin D receptors (VDR) in various tissues, particularly the intestines, bones, kidneys, and parathyroid gland. This receptor-ligand complex modulates gene expression, enhancing calcium and phosphate absorption in the gut, mobilizing calcium from bones, and reducing renal excretion of calcium, thereby maintaining serum calcium levels within a narrow physiological range.
Pharmacokinetics
- Absorption: “Cholecalciferol ” is absorbed in the small intestine, particularly in the ileum, and requires dietary fats and bile salts for optimal absorption.
- Distribution: It is transported in the bloodstream by vitamin D-binding protein (DBP).
- Metabolism: Hepatic conversion to 25-hydroxycholecalciferol, then renal conversion to the active 1,25-dihydroxycholecalciferol.
- Half-life: The half-life of 25(OH)D3 is approximately 2–3 weeks, whereas the active form has a half-life of only a few hours.
- Excretion: Mainly excreted in bile and minimally through urine.
Therapeutic Uses
| Condition | Role of Cholecalciferol |
|---|---|
| Vitamin D deficiency | Supplementation to restore serum vitamin D levels |
| Osteoporosis | Supports bone density by enhancing calcium uptake |
| Rickets (in children) | Prevents and treats deformities due to deficiency |
| Osteomalacia (in adults) | Corrects bone softening due to low vitamin D |
| Chronic kidney disease (CKD) | Manages secondary hyperparathyroidism |
| Hypoparathyroidism | Adjunct to calcium to maintain calcium homeostasis |
| Psoriasis | Topical analogs may reduce keratinocyte proliferation |
| Immune support | Modulates immune function and inflammation |
Side Effects
Cholecalciferol is generally well tolerated when used within recommended doses. However, excessive intake can lead to vitamin D toxicity (hypervitaminosis D), primarily manifested by hypercalcemia. Common side effects in such cases include:
- Nausea and vomiting
- Weakness and fatigue
- Constipation
- Polyuria and polydipsia
- Confusion or disorientation
- Kidney stones and nephrocalcinosis (with chronic high doses)
Rarely, hypersensitivity reactions such as rash or pruritus may occur.
Drug Interactions
Cholecalciferol can interact with various medications:
- Thiazide diuretics: Increase the risk of hypercalcemia.
- Glucocorticoids: May reduce vitamin D metabolism and function.
- Orlistat and Cholestyramine: Reduce absorption due to interference with fat digestion.
- Antiepileptics (e.g., phenytoin, carbamazepine): Induce hepatic enzymes that increase vitamin D catabolism.
- Digoxin: Risk of arrhythmias is increased if vitamin D-induced hypercalcemia occurs.
Caution is advised when combining vitamin D with calcium supplements or medications affecting calcium metabolism.
Safety Considerations
- Pregnancy and Lactation: Considered safe in recommended doses. Excessive doses should be avoided due to risk of fetal hypercalcemia.
- Pediatric Use: Safe and essential for growth; overuse can lead to toxicity.
- Geriatric Use: Beneficial in preventing osteoporosis; however, sensitivity to vitamin D effects may be higher in the elderly.
- Renal Impairment: Patients with CKD may require active forms like calcitriol instead of cholecalciferol.
- Monitoring: Serum 25(OH)D levels should be monitored in long-term therapy or high-dose regimens.
Regulatory Status
Cholecalciferol is classified as both a dietary supplement and prescription medication, depending on the dosage and intended use. Over-the-counter formulations are widely available in many countries for daily supplementation. In the United States, it is generally recognized as safe (GRAS) and approved by the FDA for prevention and treatment of vitamin D deficiency. High-dose formulations may require prescription depending on regional drug laws. Internationally, regulatory agencies such as the EMA (European Medicines Agency) and TGA (Australia) also approve its use in both supplementation and clinical therapy.
